Annual conference on pigment cell research
Official title: The PanAmerican Society for Pigment Cell Research (PASPCR) 25th annual conference entitled "Where pigment cell research never sleeps"
Funded at Weill Medical Coll of Cornell Univ · NIH-10999742 · Data updated 2026-11-12
The 2024 Annual Meeting of the Pan-American Society for Pigment Cell Research is bringing together experts in New York City to share the latest discoveries about skin color and related health issues, especially focusing on how these findings can help people with skin of color.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | July 18, 2024 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $29,496 |
| NIH project number | 1R13AR084871-01 |
| Project ID | NIH-10999742 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation include individuals affected by pigmentation disorders, such as albinism or vitiligo, particularly those from diverse racial and ethnic backgrounds.
✕Less likely to help
Patients with unrelated skin conditions or those not affected by pigmentation disorders may not receive direct benefits from this research.
What this research studies
The 2024 Annual Meeting of the Pan-American Society for Pigment Cell Research (PASPCR) will take place in New York City, focusing on the biology and chemistry of melanocytes and pigmentation. This conference aims to unite experts from various fields to discuss advancements in understanding pigmentation and its implications for human health and disease. A special session will be dedicated to patients with skin of color, addressing the impact of melanocyte diseases and fostering collaboration among researchers and clinicians. Attendees will have the opportunity to learn about recent findings and participate in discussions that could influence future treatments and care.
Why it matters
Potential benefit: If successful, this research could enhance understanding and treatment options for conditions related to pigmentation, benefiting patients with skin of color and related disorders.
How similar studies have gone: Previous conferences and collaborations in the field of pigment cell research have shown success in advancing knowledge and treatment approaches.
Where this research is happening
-
Weill Medical Coll of Cornell Univ
New York, United States Active
Researchers
- Principal investigator: Zippin, Jonathan Hale — Weill Medical Coll of Cornell Univ
- Study coordinator: Zippin, Jonathan Hale
Related research
Other NIH-funded projects on the same topics.
-
Destruction of noncoding RNAs in cancer
This grant funds research to understand how noncoding RNAs are broken down, which could reveal new ways to influence cancer development and progression.
-
Coaching and Navigation by Community Health Workers via Telehealth for High-Risk Hypertension
A program using telehealth and community health workers to help adults with severe hypertension connect to primary care and follow practical, heart-healthy lifestyle tips.
-
Corticospinal neurons and recovery of precise forelimb movement after spinal cord injury
This project studies how spine injuries change brain circuits and whether targeted rehabilitation helps restore precise forelimb movement.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
ROMA:Women — comparing single vs multiple arterial grafts in women undergoing CABG
A women-focused clinical trial tests whether using more arterial grafts during heart bypass surgery improves outcomes and quality of life for women.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.